Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

OBJECTIVE: We assessed CSF levels of the light chain subunit of neurofilaments (NfL) at baseline and after fingolimod therapy or placebo in patients with relapsing-remitting multiple sclerosis (RRMS). Changes in NfL levels were also correlated with relapse and MRI outcomes. METHODS: CSF samples were...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhle, Jens, Disanto, Giulio, Lorscheider, Johannes, Stites, Tracy, Chen, Yu, Dahlke, Frank, Francis, Gordon, Shrinivasan, Anupama, Radue, Ernst-Wilhelm, Giovannoni, Gavin, Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409586/
https://www.ncbi.nlm.nih.gov/pubmed/25809304
http://dx.doi.org/10.1212/WNL.0000000000001491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409586/
https://www.ncbi.nlm.nih.gov/pubmed/25809304
http://dx.doi.org/10.1212/WNL.0000000000001491

Ejemplares similares